This old drug takes a new approach to preventing heart attacks

FDA recently approved a low-dose version of a well-established drug to target cardiovascular inflammation, broadening patients’ options for potential heart attack prevention. Writing for the Wall Street Journal, Ron Winslow explains how this new treatment option could help personalize cardiovascular care.

Eight innovative strategies to improve cardiovascular care

Could an anti-inflammatory drug help prevent heart attacks?

According to Winslow, research has found a link between inflammation in the coronary arteries and the risk of heart attacks. Chronic inflammation can contribute to atherosclerosis, an artery-clogging disease. As fatty plaque builds up in the artery walls, they can sometimes rupture, leading to...